AstraZeneca PLC (AZN.L) LSE
Currency In GBp
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 287.6B |
| Enterprise Value | 311.51B |
| P/E Ratio | 25.91 |
| PEG Ratio | 1.57 |
| Price/Sales Ratio | 4.58 |
| Price/Book Ratio | 5.57 |
| Enterprise/Revenue | 5 |
| Enterprise/EBITDA | 14.62 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
Profitability
| Profit Margin | 0.18 |
| Operating Margin | 0.24 |
AD
Management Effectiveness
| Return On Assets | 0.09 |
| Return On Equity | 0.22 |
Income Statement
| Revenue | 58.74B |
| Revenue/Share | 40.25 |
| Gross Profit | 48.11B |
| EBITDA | 19.83B |
| Net Income | 10.23B |
| Diluted EPS | 6.54 |
Balance Sheet
| Total Cash | 8.11B |
| Total Cash/Share | 5.23 |
| Total Debt | 33.97B |
| Total Debt/Equity | 0.66 |
| Current Ratio | 1.01 |
| Book Value Per Share | 33.19 |
Price History
| 52-Week Change | 3.19 |
| 52-Week High | 15,732 |
| 52-Week Low | 9,892 |
| Moving Average 50 Days | 12,556.48 |
| Moving Average 200 Days | 13,441.31 |
Statistics
| Average Volume | 2.89M |
| Shares Outstanding | 1.55B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 3.17 |
| Trailing Annual Dividend Yield | 1.72 |
| Payout Ratio | 0.45 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
